查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1595261

消化性潰瘍治療藥物市場：依消化性潰瘍類型、藥物類型、通路分類 - 全球預測 2025-2030

Peptic Ulcer Drugs Market by Peptic Ulcer Type (Duodenal Ulcer, Gastric Ulcer), Drug Type (Cytoprotective Agents, H2 Blockers, Proton Pump Inhibitors (PPIs)), Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年消化性潰瘍藥物市值為45.1億美元，預計2024年將達到47.3億美元，複合年成長率為5.19%，到2030年將達到64.3億美元。

消化性潰瘍藥物市場包括用於治療和管理消化性潰瘍的藥物，消化性潰瘍是胃、小腸上部和食道內壁的病變。這些藥物包括制酸劑、質子幫浦抑制劑、H2 受體拮抗劑和針對病菌感染的抗生素。消化性潰瘍病的廣泛流行推動了對這些藥物的需求，而生活方式因素、非類固醇消炎劑的使用增加以及病菌感染的流行又加劇了這種疾病。主要用途包括治療和預防潰瘍、減少併發症和促進胃腸健康。藥品主要在醫院、診所以及由個人消費者在醫生的監督下使用。

主要市場統計
基準年[2023] 45.1億美元
預測年份 [2024] 47.3億美元
預測年份 [2030] 64.3億美元
複合年成長率（%） 5.19%

市場成長是由胃腸道健康意識增強、人口老化以及提高治療效果的配方進步等因素所推動的。此外，政府醫療保健支出的增加也為市場擴張提供了潛在的機會。為了抓住這些機遇，製藥公司應專注於探索新型藥物遞送系統，例如奈米顆粒介導的遞送和緩釋性，以提高藥物療效並最大限度地減少副作用。此外，針對基因譜量身定做的個人化醫療方法的開發仍然是一個有前途的技術創新領域。

然而，嚴格的監管要求、專利到期和高昂的藥物開發成本等挑戰可能會阻礙市場成長。他們也面臨市場競爭和長期吸毒潛在副作用的限制。由於消費者對整體療法的偏好不斷增加，創新應著重於減少抗藥性、提高幽門螺旋桿菌根除率以及開拓天然和草藥化合物空間。總體而言，消化性潰瘍治療藥物市場的特點是不斷發展的趨勢和技術的進步，因此公司策略性地投資於研發並建立聯盟以有效地增強其市場地位，利用成長機會至關重要。

市場動態：快速發展的消化性潰瘍藥物市場的關鍵市場洞察

消化性潰瘍藥物市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 由於老年人口的增加，消化性潰瘍的盛行率很高
    • 提高對消化性潰瘍的認知和診斷技術的進步
    • 越來越重視以病人為中心的照護和個人化消化性潰瘍治療
  • 市場限制因素
    • 消化性潰瘍藥物高成本
  • 市場機會
    • 介紹更新、更有效的消化性潰瘍治療方法
    • 遠距遠端醫療和電子商務平台的採用越來越多
  • 市場挑戰
    • 與消化性潰瘍藥物相關的副作用

波特五力：駕馭消化性潰瘍藥物市場的策略工具

波特的五力框架是了解消化性潰瘍藥物市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解消化性潰瘍藥物市場的外部影響

外部宏觀環境因素在塑造消化性潰瘍治療藥物市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解消化性潰瘍治療藥物市場的競爭狀況

消化性潰瘍藥物市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣消化性潰瘍藥物市場供應商的績效評估

FPNV定位矩陣是評估消化性潰瘍治療市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃消化性潰瘍藥物市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，消化性潰瘍藥物市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 隨著老年人口的增加，消化性潰瘍的盛行率也增加
      • 提高對消化性潰瘍的認知和診斷技術的進步
      • 越來越重視以病人為中心的照護和個人化消化性潰瘍治療
    • 抑制因素
      • 消化性潰瘍藥物價格高
    • 機會
      • 介紹更新、更有效的消化性潰瘍治療方法
      • 擴大遠距遠端醫療和電子商務平台的採用
    • 任務
      • 與消化性潰瘍藥物相關的不良反應
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章依消化性潰瘍類型分類的消化性潰瘍治療藥物市場

  • 十二指腸潰瘍
  • 胃潰瘍

第7章：按藥物類型分類的消化性潰瘍治療市場

  • 細胞保護劑
  • H2阻斷劑
  • 質子幫浦抑制劑 (PPI)

第8章消化性潰瘍治療藥物市場：按分銷管道

  • 離線
    • 醫院
    • 零售藥房
  • 線上

第9章北美和南美消化性潰瘍藥物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太消化性潰瘍藥物市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東與非洲消化性潰瘍藥物市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • AbbVie Inc.
  • AstraZeneca PLC
  • Boehringer Ingelheim International GmbH
  • Cadila Healthcare Ltd.
  • Century Pharmaceuticals Ltd.
  • Daewoong Pharmaceutical Co. LTD.
  • Dr. Reddy's Laboratories Ltd
  • Eisai Co. Ltd.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC
  • Hikma Pharmaceuticals PLC
  • Medopharm Pvt Ltd
  • Merck KGaA
  • Mylan NV
  • Novartis AG
  • Pfizer Inc.
  • Pharmanova India Drugs Pvt. Ltd.
  • Redhill Biopharma Ltd
  • Rosemont Pharmaceuticals Limited
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • Ulcerex Pharma
  • USAntibiotics
  • Yuhan Corporation
Product Code: MRR-2A0283E25692

The Peptic Ulcer Drugs Market was valued at USD 4.51 billion in 2023, expected to reach USD 4.73 billion in 2024, and is projected to grow at a CAGR of 5.19%, to USD 6.43 billion by 2030.

The market for Peptic Ulcer Drugs encompasses pharmaceuticals designed to treat and manage peptic ulcers, which are open sores in the lining of the stomach, upper small intestine, or esophagus. The scope includes antacids, proton pump inhibitors, H2-receptor antagonists, and antibiotics targeting H. pylori infections, among others. The necessity for these drugs is driven by the widespread prevalence of peptic ulcer disease, which is exacerbated by lifestyle factors, increased use of NSAIDs, and the prevalence of H. pylori infections. Key applications include the treatment and prevention of ulcers, reducing complications, and improving gastrointestinal health. The drugs are mainly used in hospitals, clinics, and by individual consumers under medical guidance.

KEY MARKET STATISTICS
Base Year [2023] USD 4.51 billion
Estimated Year [2024] USD 4.73 billion
Forecast Year [2030] USD 6.43 billion
CAGR (%) 5.19%

Market growth is propelled by factors such as rising awareness around gastrointestinal health, an aging population, and advancements in drug formulations that offer improved therapeutic outcomes. Additionally, the increase in government healthcare expenditure presents potential opportunities for market expansion. To seize these opportunities, pharmaceutical companies should focus on enhancing drug efficacy, minimizing side effects, and exploring novel drug delivery systems, such as nanoparticle-mediated delivery and sustained-release formulations. Moreover, the development of personalized medicine approaches tailored to genetic profiles remains a promising area for innovation.

However, challenges such as stringent regulatory requirements, patent expirations, and the high cost of drug development could hamper market growth. The market also faces limitations posed by a high level of competition and the potential side effects associated with prolonged medication use. Innovation should focus on reducing drug resistance, improving H. pylori eradication rates, and exploring the natural and herbal compound segments due to growing consumer preferences for holistic therapies. Overall, the peptic ulcer drug market is marked by evolving trends and technology advancements, making it essential for companies to strategically invest in R&D and form alliances to effectively enhance market presence and leverage growth opportunities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Peptic Ulcer Drugs Market

The Peptic Ulcer Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • High prevalence of peptic ulcers with expanding geriatric population
    • Growing awareness about peptic ulcers and advancements in diagnostic techniques
    • Increasing emphasis on patient-centric care and personalized peptic ulcer treatment
  • Market Restraints
    • High cost of peptic ulcer drugs
  • Market Opportunities
    • Introduction of newer and effective peptic ulcer drugs
    • Growing adoption of telemedicine and e-commerce platforms
  • Market Challenges
    • Adverse effects associated with peptic ulcer drugs

Porter's Five Forces: A Strategic Tool for Navigating the Peptic Ulcer Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Peptic Ulcer Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Peptic Ulcer Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Peptic Ulcer Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Peptic Ulcer Drugs Market

A detailed market share analysis in the Peptic Ulcer Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Peptic Ulcer Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Peptic Ulcer Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Peptic Ulcer Drugs Market

A strategic analysis of the Peptic Ulcer Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Peptic Ulcer Drugs Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., AstraZeneca PLC, Boehringer Ingelheim International GmbH, Cadila Healthcare Ltd., Century Pharmaceuticals Ltd., Daewoong Pharmaceutical Co. LTD., Dr. Reddy's Laboratories Ltd, Eisai Co. Ltd., F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Medopharm Pvt Ltd, Merck KGaA, Mylan N.V., Novartis AG, Pfizer Inc., Pharmanova India Drugs Pvt. Ltd., Redhill Biopharma Ltd, Rosemont Pharmaceuticals Limited, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Ulcerex Pharma, USAntibiotics, and Yuhan Corporation.

Market Segmentation & Coverage

This research report categorizes the Peptic Ulcer Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Peptic Ulcer Type, market is studied across Duodenal Ulcer and Gastric Ulcer.
  • Based on Drug Type, market is studied across Cytoprotective Agents, H2 Blockers, and Proton Pump Inhibitors (PPIs).
  • Based on Distribution Channel, market is studied across Offline and Online. The Offline is further studied across Hospitals and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High prevalence of peptic ulcers with expanding geriatric population
      • 5.1.1.2. Growing awareness about peptic ulcers and advancements in diagnostic techniques
      • 5.1.1.3. Increasing emphasis on patient-centric care and personalized peptic ulcer treatment
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of peptic ulcer drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of newer and effective peptic ulcer drugs
      • 5.1.3.2. Growing adoption of telemedicine and e-commerce platforms
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse effects associated with peptic ulcer drugs
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Peptic Ulcer Drugs Market, by Peptic Ulcer Type

  • 6.1. Introduction
  • 6.2. Duodenal Ulcer
  • 6.3. Gastric Ulcer

7. Peptic Ulcer Drugs Market, by Drug Type

  • 7.1. Introduction
  • 7.2. Cytoprotective Agents
  • 7.3. H2 Blockers
  • 7.4. Proton Pump Inhibitors (PPIs)

8. Peptic Ulcer Drugs Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Offline
    • 8.2.1. Hospitals
    • 8.2.2. Retail Pharmacies
  • 8.3. Online

9. Americas Peptic Ulcer Drugs Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Peptic Ulcer Drugs Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Peptic Ulcer Drugs Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AbbVie Inc.
  • 3. AstraZeneca PLC
  • 4. Boehringer Ingelheim International GmbH
  • 5. Cadila Healthcare Ltd.
  • 6. Century Pharmaceuticals Ltd.
  • 7. Daewoong Pharmaceutical Co. LTD.
  • 8. Dr. Reddy's Laboratories Ltd
  • 9. Eisai Co. Ltd.
  • 10. F. Hoffmann-La Roche Ltd.
  • 11. GlaxoSmithKline PLC
  • 12. Hikma Pharmaceuticals PLC
  • 13. Medopharm Pvt Ltd
  • 14. Merck KGaA
  • 15. Mylan N.V.
  • 16. Novartis AG
  • 17. Pfizer Inc.
  • 18. Pharmanova India Drugs Pvt. Ltd.
  • 19. Redhill Biopharma Ltd
  • 20. Rosemont Pharmaceuticals Limited
  • 21. Takeda Pharmaceutical Company Limited
  • 22. Teva Pharmaceutical Industries Ltd.
  • 23. Ulcerex Pharma
  • 24. USAntibiotics
  • 25. Yuhan Corporation

LIST OF FIGURES

  • FIGURE 1. PEPTIC ULCER DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. PEPTIC ULCER DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PEPTIC ULCER DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PEPTIC ULCER DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES PEPTIC ULCER DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES PEPTIC ULCER DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. PEPTIC ULCER DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. PEPTIC ULCER DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PEPTIC ULCER DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PEPTIC ULCER DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PEPTIC ULCER DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PEPTIC ULCER DRUGS MARKET DYNAMICS
  • TABLE 7. GLOBAL PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PEPTIC ULCER DRUGS MARKET SIZE, BY DUODENAL ULCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PEPTIC ULCER DRUGS MARKET SIZE, BY GASTRIC ULCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PEPTIC ULCER DRUGS MARKET SIZE, BY CYTOPROTECTIVE AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PEPTIC ULCER DRUGS MARKET SIZE, BY H2 BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PEPTIC ULCER DRUGS MARKET SIZE, BY PROTON PUMP INHIBITORS (PPIS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PEPTIC ULCER DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PEPTIC ULCER DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PEPTIC ULCER DRUGS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES PEPTIC ULCER DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 188. PEPTIC ULCER DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 189. PEPTIC ULCER DRUGS MARKET, FPNV POSITIONING MATRIX, 2023